30-Nov-2016 - IDEA Pharma and Mass Innovation Labs have announced a new collaboration aimed at changing the way the pharma industry approaches innovation.
30-Nov-2016 - Enamine and Pcovery have extended their drug discovery collaboration that focuses on creating new drugs for treating invasive fungal infections.
23-Nov-2016 - The full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council is the company’s fourth as it looks to have all of its sites...
16-Nov-2016 - Envigo has launched an integrated program of in vitro technologies that help predict the likelihood of compounds causing drug induced livery injury (DILI) as part of its new De-Risking Program.
15-Nov-2016 - Researchers in sub-Saharan Africa have developed a plug-and-play lab-on-a-chip - a ‘nontraditional approach’ to a global problem, says AAPS plenary speaker.
08-Nov-2016 - CiToxLAB has acquired AccelLAB, a preclinical medical device contract research organization (CRO) as the industry works to align the development of new drugs and medical devices.
07-Nov-2016 - Through their extended collaboration, Axiogenesis and Metrion Biosciences will further develop iPSC-derived cell based assays for drug discovery.
02-Nov-2016 - Knudra Transgenics has licensed CRISPR-Cas9 genome editing patents from ERS Genomics to turn model organisms into ‘powerful platforms for discovery,’ says CSO.
02-Nov-2016 - The NORLUX Neuro-Oncology Laboratory has installed MR Solutions’ preclinical scanner to advance cancer research and translation to clinical applications.
31-Oct-2016 - The “double edged sword” of increased regulation is a challenge, but Envigo expects outsourcing to continue as the company looks to diversity its service portfolio.
27-Oct-2016 - Envigo has collaborated with InterTek and OCSiAl to develop TUBALL™ single wall carbon nanotubes, which is the first of its kind to complete REACH registration.
26-Oct-2016 - Evotec has made an offer to acquire Cyprotex PLC, a preclinical contract research organization (CRO) specializing in ADME-Tox and DMPK.
24-Oct-2016 - ATCC has signed a strategic agreement with the contract research organization (CRO) BioAgilytix as part of its ongoing initiative to provide CRO services.
19-Oct-2016 - Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.
18-Oct-2016 - Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
18-Oct-2016 - Lovelace Biomedical launched this week as a not-for-profit preclinical contract research organization (CRO) with a business model that will let it “put science first.”
18-Oct-2016 - The U.S. Food and Drug Administration (FDA) has awarded 21 new clinical trial research grants totaling more than $23m over the next four years.
17-Oct-2016 - Thermo Fisher Scientific has revealed a preemptive pharmacogenomic risk factor screening tool to help increase drug development outcome efficiency and reduce adverse drug reactions.
17-Oct-2016 - Certara has expanded its operations as the company prepares to “fully leverage” the value of modeling and simulation in drug development.
13-Oct-2016 - Crown Bioscience has published a new version of its MuBase, its online database of efficacy/PD and humanized models, now including syngeneics, GEMM, chimeric, and allograft cancer models.
12-Oct-2016 - In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.
11-Oct-2016 - Charles River Laboratories has extended its integrated drug discovery alliance with Genentech for three additional years.
05-Oct-2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems for in vitro drug development.
03-Oct-2016 - As part of the company’s continued growth, Charles River’s recent partnership with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will work to accelerate drug development.
03-Oct-2016 - With several systems and process improvement initiatives underway, the growing contract research organization (CRO), Venn Life Sciences, continues to look for earnings enhancing opportunities, says CEO.